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The papillomavirus E2 protein is required for viral transcriptional regulation and replication. The E2 protein has a modular
structure with two highly conserved domains, a sequence-specific DNA-binding and dimerization domain and a conserved
N-terminus which is important for transcriptional transactivation, replication, and interaction with the E1 protein to determine
which specific amino acids or regions in the N-terminus were important for the replication or transactivation functions. Single
amino acid substitutions were created at highly conserved, highly charged amino acids in the HPV 11 E2 N-terminus. Each
amino acid was mutated to a nonpolar alanine residue or a similarly charged amino acid. The mutated E2 proteins were
analyzed for their abilities to support transcriptional transactivation and transient DNA replication and to enhance binding of
E1 to the origin of replication. Single amino acid substitutions were identified which were defective for either the replication
or transactivation functions, which demonstrated that the replication and transactivation functions within the N-terminus are
separable. In several cases different amino acid substitutions at the same site had variable effects on transcription or
replication, highlighting the importance of hydrophobic interactions or side chain structure at each site. The replication
function appeared to correlate with the ability of E2 to enhance binding of E1 to the origin of replication though these studies
also suggest that other functions performed by the E2 protein may be important for replication. © 1998 Academic Press
INTRODUCTION
The papillomavirus E2 protein plays a critical role in
viral transcriptional regulation and replication. The full-
length bovine papillomavirus (BPV) E2 protein is a strong
transcriptional regulator which binds as a dimer to a
palindromic DNA sequence, ACCN6GGT. The full-length
BPV E2 protein was originally shown to be a strong
transactivator of several viral promoters (reviewed in
McBride et al., 1991). More recently, promoters in the
HPV genomes, particularly HPV 16 P97 and HPV 18 P105,
have been identified which are repressed by the full-
length BPV or HPV E2 proteins (Bernard et al., 1989;
Romanczuk et al., 1990; Thierry and Howley, 1991). Pap-
illomavirus transcriptional regulation requires the DNA
binding function of the E2 protein and may also be
affected by protein interactions between E2 and other
cellular transcription factors including Sp1, TFIID, and
TFIIB (Li et al., 1991; Rank and Lambert, 1995; Steger et
al., 1995). Replication of papillomavirus DNA also re-
quires the full-length E2 protein. The E1 and E2 proteins
are the only two viral proteins required for transient BPV
replication (Ustav and Stenlund, 1991). The E1 protein is
a nuclear phosphoprotein with ATP-binding and helicase
activity which binds specifically to the BPV origin of
replication (Seo et al., 1993; Ustav et al., 1991; Wilson and
Ludes-Meyers, 1991; Yang et al., 1993). The E2 protein
enhances binding of E1 to the origin of replication and
this cooperative binding requires an E2-binding se-
quence (Lusky et al., 1993; Mohr et al., 1990; Ustav et al.,
1991; Yang et al., 1991). The BPV-1 E2 protein plays
several other roles in viral replication. The BPV-1 E2
protein may bind to replication protein A, an essential
cellular replication factor, and E2 helps relieve nucleo-
some-mediated repression of replication (Li and
Botchan, 1993, 1994). Therefore, E2 seems to affect viral
transcription and replication through protein–DNA inter-
actions and protein–protein interactions.
The structure and function of the BPV-1 E2 protein has
been studied extensively. The highly conserved N-termi-
nal 200 amino acids are crucial for transcriptional acti-
vation (Giri and Yaniv, 1988; Haugen et al., 1988; McBride
et al., 1989, 1988; Winokur and McBride, 1992). More
recently, studies have determined that this domain is
also crucial for replication and cooperative origin binding
by the E1 and E2 proteins (Berg and Stenlund, 1997;
Winokur and McBride, 1992, 1996). Additionally, yeast
two hybrid studies have shown that the N-terminal 91
amino acids of BPV-1 E2 interact with the BPV-1 E1
protein (Benson and Howley, 1995).
Much less work has been done to analyze the various
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domains of the HPV E2 proteins. Combinations of several
E1 and E2 proteins from various HPVs and BPV-1 are
able to support replication of homologous and heterolo-
gous origins of replication (Chiang et al., 1992b; Del
Vecchio et al., 1992). Therefore, many of the functions
and interactions among the cis and trans factors impor-
tant for papillomavirus replication appear quite con-
served. As in the BPV-1 E2 protein, the HPV 16 E2
N-terminus appears to mediate interaction with the E1
protein since a monoclonal antibody which recognizes
amino acids 18 to 41 of the HPV 16 E2 protein disrupts
interaction with the HPV 16 E1 protein (Hibma et al.,
1995). However, differences in the various E2 proteins
have recently been identified. The HPV 16 E2 protein is a
much stronger transactivator than is the HPV 11 E2
protein (Kovelman et al., 1996) and the HPV 11 E2 protein
cannot support replication when paired with the BPV E1
protein and the BPV origin of replication (Berg and Sten-
lund, 1997). Therefore additional studies that analyze the
HPV E2 proteins may reveal mechanisms which underlie
these different phenotypes.
Given the absolute requirement for the N-terminus
in transcription, replication, and cooperative origin
binding, we were interested in analyzing whether the
N-terminal domain contains separate functional sub-
domains which are required for each function and
whether the abilities of the N-terminus to support
replication and transcriptional activation can be sep-
arated. The HPV 11 E2 protein was used for these
studies to begin to develop a better understanding of
how the HPV E2 proteins function in replication and
transactivation. Site-directed mutagenesis was used
to mutate highly conserved, charged amino acids in
the transactivation domain of the HPV 11 E2 protein. To
help determine whether charge contributed to an im-
portant secondary structure or whether particular
amino acids had specific functions, each amino acid
was mutated to a nonpolar alanine or a similarly
charged amino acid. The replication, transactivation,
and cooperative origin binding functions of each mu-
tated protein were analyzed. Single amino acid muta-
tions were identified which separated the replication
and transactivation functions of the HPV 11 E2 protein.
Our mutagenesis strategy also highlighted how differ-
ent mutations in the same amino acid can significantly
alter function. Finally, some of the mutations identified
in the HPV 11 E2 protein have very similar phenotypes
in the HPV 16 and BPV-1 E2 proteins, suggesting that
the multifunctional E2 proteins are conserved to a
large degree (Abroi et al., 1996; Brokaw et al., 1996;
Ferguson and Botchan, 1996; Sakai et al., 1996).
RESULTS
The E2 proteins from many animal and human papillo-
maviruses share a conserved N-terminus which, in the
case of the BPV-1 E2 protein, is required for transcriptional
regulation, viral DNA replication, and cooperative origin
binding (Berg and Stenlund, 1997; Giri and Yaniv, 1988;
Haugen et al., 1988; McBride et al., 1989; McBride et al.,
1988; Winokur and McBride, 1992, 1996). The multifunc-
tional and highly conserved nature of the N-terminus sug-
gested that this region might have distinct subdomains
which are crucial for each function. To address this hypoth-
esis, targeted mutagenesis was performed to identify criti-
cal amino acids important for the replication, transcriptional
regulation, and cooperative origin binding functions within
the HPV 11 E2 N-terminus. Amino acid sequences from
various HPVs, BPV-1, and several other animal papilloma-
viruses were aligned and highly conserved amino acids
were identified. Since polar amino acids are frequently
displayed on the surface of folded proteins or contribute to
important secondary structures, highly conserved, charged
amino acids were identified to further prioritize this mu-
tagenesis strategy. Figure 1 identifies the 12 conserved,
charged amino acids which were targeted for mutagenesis.
Single mutations were introduced into the E2 ORF to sub-
stitute either a nonpolar alanine or a similarly charged
FIG. 1. The amino acid sequence of the N-terminus from the HPV 11 E2 protein. Highly conserved, highly charged amino acids are shown in shaded
boxes. A selection of these conserved, charged amino acids were mutated to either an alanine residue or a similarly charged amino acid residue.
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amino acid. For example, the arginine residue at position 7
was mutated either to an alanine or to a lysine residue. The
combination of a nonpolar and charged amino acid substi-
tution was designed to highlight the importance of charge,
structure, or side chains on E2 functions.
Expression of mutated E2 proteins
To determine whether single amino acid substitu-
tions affected the expression or stability of the mu-
tated E2 proteins, immunoblot analyses of cells trans-
fected with each mutated pCMV-E2 expression vector
were performed. Rabbits were immunized with a fu-
sion protein containing GST fused in-frame to the
hinge and C-terminal domain of HPV 11 E2. The re-
sulting polyclonal serum was specific for the HPV 11
E2 protein and affinity-purified antibodies functioned
in immunoblot and immunoprecipitation assays. Cell
lysates from COS 7 cells transfected with the pCMV-E2
vectors were assayed for E2 expression using stan-
dard immunoblot techniques (Fig. 2). Affinity-purified
E2-specific serum detected a 43-kDa protein which
was present in cells transfected with the wild-type E2
expression vector but was absent in mock-transfected
cells and cells transfected with the pCMV vector
alone. Two proteins which migrated at 46 and 47 kDa
were detected in control cells as well as pCMV-E2-
transfected cells and likely represent cellular crossre-
active proteins. Each mutated vector also expressed a
43-kDa protein which comigrated with wild-type E2
protein. Though minor variations in protein content
were identified in each specific cell transfection and
immunoblot assay, overall expression of each 43-kDa
mutated E2 protein was comparable to expression
from the wild-type E2 vector.
Analysis of the transcriptional activation properties of
mutated E2 proteins
Standard transient transcription assays were per-
formed with each mutated E2 expression vector to de-
termine whether single amino acids in the N-terminus of
the HPV 11 E2 protein affect the ability of the protein to
activate transcription from an E2-responsive promoter.
HeLa cells were cotransfected with pTKM-11 and wild-
type or mutated pCMV-E2 vectors. pTKM-11 is a chlor-
amphenicol acetyl transferase (CAT) reporter construct
which contains six tandem E2-binding sites upstream
from the herpes simplex virus TK promoter (Thierry et al.,
1990). Wild-type HPV 11 E2 protein activated CAT expres-
sion 20-fold over the basal CAT activity detected in cells
transfected with pTK-11 alone. Nearly half of the mutated
E2 proteins, R7A, R37A, R37K, E39D, E74A, E74D, E90A,
E90D, D96A, K111A, and K111R, were significantly im-
paired for their ability to activate transcription (Fig. 3). In
many but not all cases, the alanine and conservative
amino acid substitution at any one amino acid behaved
similarly. The data shown in Fig. 3 were obtained from
transfections performed in HeLa cells. The HeLa cervical
carcinoma cell line contains multiple copies of HPV 18
though the copies are interrupted in the E2 region of the
FIG. 3. Transcriptional activation and replication activities mediated
by wild-type and mutated E2 proteins in HeLa cells. HeLa cells were
transfected with pTKM-11, an E2-responsive CAT reporter plasmid,
alone or with pCMV-E2 or mutated pCMV-E2. Wild-type E2 protein
activated CAT expression 20-fold over the basal CAT activity detected
in cells transfected with pTKM-11 alone. Each plasmid was tested in
three to five independent assays. The CAT activity generated by ex-
pression of the wild-type E2 protein was assigned a value of 100% and
the CAT activities generated by each mutated E2 expression vector
were compared to this value. R7K and E118A activated transcription at
217 and 317%, respectively. Replication assays were performed three to
five times as described in the legend to Fig. 4 and the results from each
independent assay were averaged. The quantity of replicated origin
DNA supported by the wild-type E2 protein was assigned a value of
100% and each mutant was compared to this value. Transactivation and
replication activities were also analyzed in C33a cells and results were
similar to those identified in HeLa cells.
FIG. 2. Immunoblot analysis of proteins expressed by each mutated
pCMV-E2 expression vector. COS 7 cells were transfected with each E2
expression vector. Protein lysates were analyzed in immunoblot stud-
ies using an affinity-purified polyclonal rabbit serum which recognizes
the C-terminus of the HPV 11 E2 protein. Lane 1 in each panel shows
mock-transfected COS 7 cell lysate, Lane 2 contains lysate from cells
transfected with the pCMV4 vector, and subsequent lanes display
protein lysates from cells transfected with pCMV-E2 or mutated
pCMV-E2 vectors. Each E2 protein migrated at 43 kDa.
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virus. To analyze whether these copies of papillomavirus
interfered with interpretation of the transcriptional regu-
latory properties of our mutated E2 proteins, studies
were also performed in C33a cells, a cervical cancer cell
line which does not contain any known HPV sequences.
The results were very similar to those obtained in HeLa
cells (data not shown). Thus single amino acid substitu-
tions within highly conserved charged amino acids in the
HPV 11 E2 N-terminus did significantly affect the ability of
the protein to support the transactivation function. The
number of substitutions which affected transcriptional
regulation supports the thought that the N-terminus is
tightly configured and even subtle mutations can signif-
icantly affect function.
Transient DNA replication supported by mutated HPV
11 E2 proteins
Only two viral proteins, E1 and E2, are required for
transient papillomavirus DNA replication (Ustav and
Stenlund, 1991). The next experiments were designed to
determine whether the mutated E2 proteins can support
the replication function and whether the N-terminus has
specific regions which are more important for the repli-
cation or the transactivation function. HeLa cells were
cotransfected with a plasmid containing the HPV 11
origin of replication (nt 7072–576), pCMV-E111, and wild-
type or mutated pCMV-E211 vectors. Low molecular
weight DNA was harvested from the cells after 72 h and
digested with BamHI and DpnI. The DNA fragments were
analyzed by Southern blot hybridization using an HPV 11
origin probe containing nucleotides 7072–576 (Fig. 4).
DpnI cleaves methylated, bacterial input DNA while DNA
replicated within mammalian cells is unmethylated and
DpnI resistant. Consequently, replicated HPV 11 ori DNA
migrated as a linear 4.3-kb fragment while the bacterial
input DNA ran as faster migrating species. The repli-
cated and input DNA fragments were quantitated and the
replication activity was standardized to the transfection
efficiency as determined by the quantity of bacterial input
DNA in each specimen.
Five mutated E2 proteins were defective in their ability
to support transient papillomavirus DNA replication (Fig.
3). In particular, E39A, E39D, E90A, K111A, and K111R
replicated at levels less than 10% of that seen with
wild-type E2 protein. E118A also replicated poorly, sup-
porting replication approximately 20% as well as wild-
type E2 protein. As mentioned above, it was important to
determine whether endogenous HPV sequences in HeLa
cells affected the replication assays. Transient replica-
tion assays were also performed in C33a cells and,
though the transfection efficiency was less in these cells
making the replication signal weaker, the replication
phenotypes of each mutated E2 protein were similar in
the two cell lines (data not shown). Therefore, single
amino acid substitutions in the E2 protein also affected
the ability of these E2 proteins to support replication.
The transcriptional regulation and replication
properties of the E2 protein are separable
When the transcription and replication phenotypes of
each mutant were compared, certain amino acid substi-
tutions were found to affect either the transcriptional
regulation or replication function (Fig. 3). Seven mutated
E2 proteins, R7A, R37A, R37K, E74A, E74D, E90D, and
D96A, were able to support replication as well as wild-
type E2 protein but were unable to transactivate an
E2-responsive promoter. Two proteins, E39A and E118A,
were able to activate transcription as well or better than
wild-type E2 protein yet were severely impaired for rep-
lication. Immunoblot studies demonstrated that each of
these mutated proteins was expressed and was as sta-
ble as wild-type E2 protein so the transcription and
replication phenotypes cannot be explained by differ-
ences in protein concentration. Four proteins, E39D,
E90A, K111A, and K111R, were significantly impaired for
both the transcription and replication functions. Though it
FIG. 4. Transient replication activity supported by wild-type or mutated E2 proteins. HeLa cells were transfected with pKSori11 alone, pKSori11 with
pCMV-E1 or with both plasmids and pCMV-E2 or mutated pCMV-E2 as indicated. Origin DNA was detected by Southern blot analysis. Replicated
origin DNA migrated at 4.3 kb as indicated while bacterial input origin DNA was cleaved into smaller fragments. The quantities of replicated DNA
were quantitated with a PhorphorImager and were standardized to the amount of bacterial input DNA transfected into the cell.
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is possible these mutations affected both functions and
identified a functional overlap between replication and
transactivation, this phenotype may more likely be ex-
plained by a significant alteration in protein conformation
or loss of nuclear localization. Overall, single amino
acids were identified which are more important for the
replication or transcriptional regulation function, demon-
strating that the replication and transactivation in the
N-terminus of the HPV 11 E2 protein are separable.
Cooperative origin binding by the E1 and E2 proteins
The papillomavirus origins of replication are com-
prised of a central binding site for the E1 protein which
is flanked on either side by E2-binding motifs. The BPV-1
E1 protein alone binds weakly to the origin but this
binding is enhanced by the addition of E2 protein (Lusky
et al., 1993; Mohr et al., 1990; Yang et al., 1991). Addition-
ally, the E1 and E2 proteins form a tight complex with
each other (Blitz and Laimins, 1991; Lusky and Fontane,
1991; Mohr et al., 1990). It is thought that the E2 protein
enhances E1 origin binding through both protein–protein
and protein–DNA interactions. Studies suggest that the
E2 N-terminus plays an important role in E1–E2 protein
interactions (Benson and Howley, 1995; Berg and Sten-
lung, 1997; Hibma et al., 1995; Winokur and McBride,
1996). Therefore, E1–E2 protein interaction studies were
performed on the panel of HPV 11 E2 carrying point
mutations in the N-terminus to examine correlations be-
tween replication and cooperative origin binding. Direct
protein coimmunoprecipitation studies analyzing the in-
teractions between the HPV 11 E1 and E2 proteins were
performed but studies were limited by nonspecific bind-
ing seen with the E2 protein (data not shown). To deter-
mine whether the replication phenotypes of the mutated
HPV 11 E2 proteins could be explained by the ability of
each protein to enhance binding of E1 to the origin of
replication, mutated HPV 11 E2 proteins were analyzed in
DNA–protein coimmunoprecipitation assays. Aliquots of
in vitro expressed E2 proteins were analyzed by gel
electrophoresis and the concentration of each mutated
E2 protein was standardized to ensure that equal quan-
tities of wild-type or mutated E2 protein were used for
each assay. The HPV 11 long control region contains four
E2-binding motifs, three of which closely flank the origin
of replication. Radiolabeled fragments of DNA consisting
of the origin of replication with the four E2-binding motifs
(nt 7875–130) and two nonspecific plasmid DNA, one
fragments, were mixed with in vitro expressed E1 protein
alone or E1 protein and wild-type or mutated E2 protein.
The proteins were immunoprecipitated with an E1-spe-
cific polyclonal rabbit serum. Coprecipitating DNA frag-
ments were analyzed by gel electrophoresis (Fig. 5A).
Assays were performed using approximately 1.5- to
2-fold excess of E2 protein to E1 protein. Cooperative
origin binding was not saturated under these conditions
(data not shown).
As other laboratories have demonstrated, HPV 11 E1
protein alone bound the HPV 11 origin fragment poorly,
often precipitating labeled origin DNA detectable only
with prolonged exposure during autoradiography (Bream
et al., 1993; Chiang et al., 1992a; Kuo et al., 1994). Addi-
tionally, little or no origin DNA was coprecipitated when
the E2 protein was immunoprecipitated with the E1-
specific serum. However, when both HPV 11 E1 and E2
proteins were present, 185-fold more origin DNA was
coprecipitated. This contrasts with the BPV-1 assays.
BPV-1 E1 can bind its origin sequence much better than
does the HPV 11 E1 protein, and the addition of BPV-1 E2
protein only enhances E1 binding 17-fold (Brokaw et al.,
1996). Each mutated E2 protein was analyzed for coop-
erative origin binding. The majority of mutated E2 pro-
teins enhanced E1 origin binding as well as did wild-type
E2 protein (Fig. 5B). However, E39A, which was unable
to support replication, could only enhance binding
approximately 26-fold, which was approximately 14%
of wild-type E2 activity. K112R also enhanced binding
poorly though this mutation also depleted the replica-
tion and transactivation functions, suggesting that this
protein may have a more global defect in folding which
renders the protein nonfunctional. E20D enhanced
binding approximately 35% as well as wild-type E2
protein and replicated about half as well as wild-type
E2 protein, suggesting that the degree of cooperative
binding may correlate with the efficiency of replication.
However, the ability to enhance E1 origin binding is
not the only relevant factor since E118A enhanced
binding quite well but replicated poorly. These data
suggest that an interaction between the E1 and E2
protein is crucial for the replication function. However,
other factors may also be important for the replication
function. The activities of mutated E2 proteins are
summarized in Table 1.
DISCUSSION
The papillomavirus E2 protein is a multifunctional pro-
tein which is crucial for viral pathogenesis. Papillomavi-
rus genomes containing mutations in the E2 open read-
ing frame have altered viral transcription and replication
as well as differences in their abilities to induce cellular
proliferation (DiMaio, 1986; DiMaio and Settleman, 1988;
Hermonat and Howley, 1987; Romanczuk and Howley,
1992). Previous studies have determined that the highly
conserved N-terminus of the BPV-1 E2 protein is required
for the transcription and replication functions and this
region is also required for cooperative origin binding
with the papillomavirus E1 protein (Giri and Yaniv, 1988;
Haugen et al., 1988; McBride, et al., 1989; Winokur and
McBride, 1992, 1996). The similarities in protein structure
and function have suggested that the various E2 proteins
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may be quite similar. However, recent studies have be-
gun to identify differences between the various E2 pro-
teins (Berg and Stenlund, 1997; Kovelman et al., 1996). In
this study, point mutations in the HPV 11 E2 N-terminus
have been identified which abolish either the replication
or transcriptional activation functions of the protein.
Other laboratories have reported similar studies for the
BPV-1 and HPV 16 E2 proteins (Abroi et al., 1996;
Breiding, 1996; Brokaw et al., 1996; Ferguson and
Botchan, 1996; Sakai et al., 1996). This study, though,
systematically compared several mutations at each
amino acid site. Our data support previous studies which
have identified particular conserved amino acids in the
N-terminus of the E2 protein which are crucial for either
the replication or transactivation function. These studies
also offer new insights into the requirements for charge,
hydrophobicity, or side chain structure at various amino
acid positions.
Alanine substitution mutagenesis has been used to
identify critical amino acids in several studies (Cunning-
ham and Wells, 1989; Thukral et al., 1991). Alanine resi-
dues are small compact structures which lack a side
chain and induce no significant electrostatic or steric
effects. Therefore, these residues seem compatible with
all protein secondary structures and do not appear to
induce conformational or structural changes (Cunning-
ham and Wells, 1989). In this study, highly charged con-
served amino acids were substituted with either an ala-
nine residue or a similarly charged amino acid. It was
thought that these amino acid substitutions would mini-
mally affect secondary structure and might highlight im-
portant side chains needed for E2 functions. Many point
mutations affected the transactivation function of the
HPV 11 E2 protein. Moreover, both the alanine and the
conserved substitution at each site affected transactiva-
tion similarly, suggesting that the transactivation function
FIG. 5. (A) Cooperative origin binding by each E2 protein. Radiolabeled DNA containing the origin, p11ori, was reacted with in vitro translated E1
protein alone or in addition to in vitro translated wild-type or mutated E2 protein as indicated. The E1 protein was immunoprecipitated with a
polyclonal rabbit serum specific for the C-terminus of the HPV 11 E1 protein. HPV 11 E1 protein bound the origin DNA very poorly but binding was
enhanced 185-fold in the presence of wild-type HPV 11 E2 protein. The quantity of precipitated origin DNA was quantitated using a PhosphorImager
and the quantity of DNA precipitated by wild-type E2 protein was assigned a value of 100%. Each mutated E2 protein was analyzed three to five times
for its ability to enhance origin binding by the E1 protein. (B) Graphic representation of the ability of each mutated protein to support cooperative origin
binding by the E1 protein.
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supported by the E2 N-terminus has very strict amino
acid requirements. In support of this concept, several
amino acid substitutions which affected HPV 11 E2 pro-
tein also affected the HPV 16 and BPV E2 proteins.
Mutations at amino acids 37 and 74, either the alanine
substitution or the similarly charged amino acid substi-
tution, significantly impaired transactivation. Amino acid
74 was also critical for transcriptional regulation sup-
ported by the HPV 16 E2 and BPV E2 proteins (Abroi et
al., 1996; Ferguson and Botchan, 1996). Amino acid 37,
though, seems to be more critical in the HPV 11 and HPV
16 E2 proteins than the BPV E2 protein (Abroi et al., 1996;
Brokaw et al., 1996; Ferguson and Botchan, 1996; Sakai
et al., 1996). Mutations at amino acids 7 and 90 greatly
affected the transcription function of the HPV 11 E2
protein but had less effects on the other E2 proteins
(Ferguson and Botchan, 1996; Sakai et al., 1996). Amino
acids 7, 37, and 74 lie within predicted acidic a-helices
which may be important for the transactivation function
(Giri and Yaniv, 1988; Haugen et al., 1988; Lambert et al.,
1989; McBride et al., 1989). It is likely that these charged
amino acids contribute to the a-helix structure but
charge alone may not explain their functional or struc-
tural role since conserved amino acid substitutions
could not preserve function. Possibly, amino acids 37
and 74 provide bonding properties that cannot be sup-
ported by a similarly charged amino acid or the nonpolar
alanine residue. For example, arginine (R) residues act
solely as hydrogen-bond donors while lysine (K) residues
can act as hydrogen bond donors or acceptors at phys-
iological pH.
Mutations at amino acids 37 or 74 may identify regions
of the E2 protein which affect interactions with important
cellular transcription factors. The BPV E2 protein inter-
acts with the cellular transcription factor Sp1 and the two
proteins cooperate to support transcriptional activation
(Li et al., 1991). The N-terminus of the E2 protein is
required for this interaction (Li et al., 1991). Other tran-
scription factors may also bind BPV E2, including TBP
and TFIIB, though they appear to interact with the hinge
region or the C-terminal DNA-binding and dimerization
domain of the E2 protein (Rank and Lambert, 1995; Ste-
ger et al., 1995). However, mutations in the N-terminus
could affect the overall folding of the E2 protein and the
DNA-binding domain.
Our studies also identified one amino acid substitution
(E39A) which is more important for the replication func-
tion than the transactivation function. The replication
properties of mutations in the N-terminus of the HPV 11
E2 protein showed similarities to those in the HPV 16 and
BPV E2 proteins. Alanine mutation at amino acid 39
(E39A) abolished the replication function in all three
proteins (Ferguson and Botchan, 1996; Sakai et al., 1996).
However, in our studies, E39D functioned poorly in both
replication and transcription, suggesting that substitution
of an aspartic acid (D) for a glutamic acid (E) residue
created a more functionally deleterious mutation than did
substitution with a compact, nonpolar alanine residue.
Aspartate and glutamate differ only in the length of their
side chain with glutamate having one extra carbon in the
chain. Brokaw et al., (1996) also created a nonfunctional
E39D mutation in BPV-1, highlighting the finding that the
glutamate to aspartate substitution at this amino acid
position greatly alters function.
E2 appears to recruit and enhance binding of the viral
E1 protein to the origin of replication where E1 can
provide DNA-dependent ATPase, DNA-dependent heli-
case, and DNA unwinding activities (Lusky et al., 1993;
Mohr et al., 1990; Seo et al., 1993; Yang et al., 1991). E2
may also interact with the cellular factor replication pro-
tein A (RPA) which is required for initiation of replication
and may help disrupt chromatin structure around the
origin of replication, allowing viral and cellular replication
factors greater access to the origin of replication (Li and
Botchan, 1993, 1994). Cooperative origin binding be-
tween E1 and E2 requires the N-terminal domain of the
E2 protein (Berg and Stenlund, 1997; Winokur and
McBride, 1996). Additionally, the E2 N-terminus may me-
diate protein interactions with RPA (Li and Botchan,
1993). These studies suggested that the replication phe-
notype of E39A might correlate with the ability of this
mutated protein to enhance binding of HPV 11 E1 to the
TABLE 1
Summary of Functional Activities Supported by Mutated
HPV 11 E2 Proteins
Mutant Transactivation Replication
Cooperative origin
binding
WT E2 111 111 111
R7A 2 111 111
R7K 1111 111 111
E20A 11 111 111
E20D 11 11 1
R37A 2 111 111
R37K 2 111 111
E39A 111 2 1
E39D 1 2 11
E74A 2 111 111
E74D 2 111 111
E90A 2 1 11
E90D 2 111 111
D96A 2 11 11
D96E 1 111 111
E100A 11 111 111
E100D 111 111 111
K111A 2 2 111
K111R 2 2 1
K112R 11 111 111
E118A 1111 1 111
E118D 1111 11 111
D122A 11 111 11
D122E 111 111 111
Note. 111, .80% of wild-type activity; 11, 40–80%; 1, 10–39%; 2,
,10%; 1111, .160%.
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origin of replication. Cooperative origin binding may be
particularly important in HPV 11 for several reasons.
First, HPV 11 replication absolutely requires an intact
E2-binding site (Chiang et al., 1992a; Kuo et al., 1994; Lu
et al., 1993). Second, HPV 11 E1 protein binds less well to
the origin of replication than does the BPV E1 protein. In
similar in vitro cooperative binding assays, BPV E2 en-
hanced E1 origin binding approximately 17-fold while
HPV 11 E2 enhanced E1 origin binding 185-fold (Brokaw
et al., 1996; Winokur and McBride, 1996, and data
shown). Though a strict numerical comparison may not
be feasible given the different experimental conditions
between the two laboratories, it is clear that HPV 11 E2
contributes more to E1 origin binding than does BPV-1 E2
in the homologous system. The E39A mutation was sig-
nificantly depleted for cooperative origin binding activity
but activity was not entirely abolished. These results may
suggest that this degree of cooperative origin binding is
not sufficient to support transient replication in HPV 11.
However, these cooperative origin binding assays were
performed with a slight excess of E2 protein (1.5- to 2-fold
excess). Though these conditions did not lead to satu-
ration in in vitro cooperative origin binding, in vivo E2
concentrations may be less abundant creating a more
significant effect on cooperative origin binding. In a more
direct assay, BPV-1 E39A was unable to interact with BPV
E1 in coimmunoprecipitation studies (Sakai et al., 1996).
Similar studies in the HPV 11 system were limited by
nonspecific binding by the HPV 11 E2 protein. Our stud-
ies do suggest though that impaired origin binding cor-
relates with impaired replication, similar to recent stud-
ies by Berg and Stenlund (1997). Conversely, the fact that
E118A enhanced E1 origin binding normally yet repli-
cated poorly suggests that cooperative origin binding is
not entirely responsible for efficient replication. Possibly
this mutation affects binding between E2 and RPA or
other cellular factors important for replication.
E2 proteins contain nuclear localization signals which
allow the protein to be translocated from the cytoplasm
to the nucleus. A pair of basic lysine residues at amino
acids 111 and 112 play a crucial role in nuclear translo-
cation in the BPV-1 E2 protein particularly when muta-
tions disrupt charge at this site (Abroi et al., 1996; Ski-
adopoulos and McBride, 1996). Mutations in this region
also can create large, nonfunctional protein aggregates
(Abroi et al., 1996). These findings likely explain why HPV
11 E2 mutations at amino acid 111 inactivated both the
replication and transactivation functions. Interestingly,
we were unable to create the K112A mutation using
oligonucleotide-based mutagenesis possibly because
this mutation created significant conformational changes
which interfered with mutagenesis. However, the more
conservative mutation, K112R, supported both replication
and transactivation in our studies and in the BPV-1 E2
protein (Brokaw et al., 1996). Together these results sug-
gest that basic amino acids at amino acids 111 and 112
are particularly critical for nuclear localization and prob-
ably contribute to overall protein conformation.
In conclusion, no specific linear regions within the E2
N-terminus appear to be associated with the replication
or transactivation functions of the protein. Rather specific
amino acids have been identified which separate the
replication and transactivation functions. These specific
amino acids and the phenotypes associated with muta-
tions at these sites are highly conserved among the
three E2 proteins which have been studied. Analysis of
multiple mutations at each conserved amino acid has
provided additional insight into how charge or amino
acid side chain composition may contribute to a func-
tional protein. The significance of these point mutations
will be further elucidated by three-dimensional structure
analyses of the full-length E2 protein and by protein
interaction studies looking at binding between E2 and
other viral or cellular factors.
MATERIALS AND METHODS
Plasmid constructs
Mammalian expression vectors which express the full-
length HPV 11 E1 and E2 proteins from the CMV imme-
diate early promoter, pCMV-E111, and pCMV-E211 have
been described previously and were a generous gift from
Carl C. Baker (Del Vecchio et al., 1992). Oligonucleotide-
directed mutagenesis was used to create single amino
acid substitutions in conserved amino acids in the N-
terminus of the HPV 11 E2 protein (Transformer Mu-
tagenesis, Clontech). Mutations were confirmed by DNA
sequence analysis (Sequenase, USB). Wild-type E1 and
wild-type and mutated E2 open reading frames were
subcloned into the in vitro expression vector pSP72 (Pro-
mega). Two plasmids containing the origin of replication
were used, pKSori11 contains HPV 11 nucleotides 7072–
576 and p11ori contains HPV 11 nt 7875–130 (Del Vec-
chio et al., 1992).
Transcriptional activation assay
HeLa or C33a cells were transfected using the calcium
phosphate technique and protein extracts were prepared
and analyzed as previously described (Spalholz et al.,
1985). Briefly, 0.5 mg of pCMV-E211 or mutated pCMV’s-
E211 DNA and 3 mg of pTKM-11, an E2-responsive chlor-
amphenicol acetyl transferase plasmid, were cotrans-
fected. Cells were subjected to glycerol shock, washed
in Dulbecco’s modified Eagle medium (DMEM; Gibco-
BRL), and fed with DMEM supplemented with 10% fetal
calf serum (Gibco BRL). Cell lysates were prepared 36 h
later. Protein concentrations were determined for each
lysate and equal quantities of protein were tested for
CAT activity. The amounts of acetylated and unacetylated
chloramphenicol were quantitated using a PhosphorIm-
ager (Molecular Dynamics). Each plasmid was tested in
two to four independent studies in each cell line.
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Transient replication assay
Transient replication assays were performed as previ-
ously described with the exception of the transfection
technique (Ustav and Stenlund, 1991). Dishes (100-mm2)
of subconfluent HeLa or C33a cells were transfected
using a standard calcium precipitation method. Five mi-
crograms each of pKSori11, pCMV-E1, and pCMV-E2 were
mixed with salmon sperm carrier DNA to a total of 50 mg
of DNA per dish. Cells were exposed to the calcium
precipitate for 4–5 h (C33a cells) or 12–14 h (HeLa cells),
glycerol shocked, and provided with DMEM supple-
mented with 10% fetal calf serum, penicillin, and strep-
tomycin. Cells were split 1:3 after 24 h to keep cells
actively growing. Low molecular weight DNA was har-
vested at 72 h, digested with DpnI and BamHI, electro-
phoresed on an agarose gel, and transferred to Nytran
(Schleicher & Schuell). Blots were probed with 32P-la-
beled HPV 11 ori DNA (nt 7072–576) which was cleaved
from pKSori11 and labeled using a random primer label-
ing system (Boehringer–Mannheim). Radioactive bands
were quantitated using the Phosphorimager.
Immunoblots
Cos 7 cells were electroporated as previously de-
scribed (Ustav and Stenlund, 1991). Five million cells
were mixed with 5 mg of plasmid DNA and 50 mg of
salmon sperm carrier DNA. The cells were electropo-
rated at 190 V, 960 mV with a Bio-Rad Gene Pulser. The
cells were plated onto 100-mm2 dishes, incubated for
48 h, and then washed and resuspended in SDS sample
buffer. The cell lysates were electrophoresed and trans-
ferred to nitrocellulose, and immunoblots were per-
formed with affinity-purified E2-specific antibody de-
scribed below, horseradish peroxidase-linked donkey
a-rabbit serum (Amersham), and enhanced chemilumi-
nescence reagents (Pierce).
Antisera
PCR was used to amplify a fragment of DNA encoding
the carboxyl terminus of the HPV 11 E1 protein (nt 2105–
2762) which contained a BamHI restriction site at the 59
end and an EcoRI site at the 39 terminus. This fragment
was cloned into pRSETC (Invitrogen) creating a bacterial
expression vector which expressed the in-frame HPV 11
E1 C-terminus from the lacZ controlled T7 promoter. The
pRSET-E1C plasmid was grown in the BL21(DE3) strain
of Escherichia coli and the T7 promoter was induced
with 100 mM IPTG. The bacteria were harvested and
lysed, and the supernatant fraction was electrophoresed
on a 12% SDS–acrylamide gel. The 29-kDa E111C protein
was excised from the gel and lyophilized. The lyophilized
powder was mixed with complete or incomplete Freund’s
adjuvant and used to immunize two New Zealand white
rabbits. Similarly, the hinge and C-terminal portion of the
HPV 11 E2 protein (nt 3320–3826) was amplified by PCR
with EcoRI sites at the 59 and 39 termini and was cloned
in-frame into pGEX 3X (Pharmacia Biotech) to create a
bacterial plasmid which expressed a glutathione S trans-
ferase–E2C fusion protein. HB101 E. coli were trans-
formed with pGEX-E2C and were induced with 40 mM
IPTG. The bacteria were harvested and lysed, and the
soluble GST–E2C fusion protein was isolated on gluta-
thione–agarose. The 48-kDa GST–E211C protein was re-
leased from the glutathione agarose beads and mixed
with Freund’s or incomplete Freund’s adjuvant and used
to immunize two New Zealand white rabbits. Rabbit im-
munizations and production bleeds were performed by
HTI Bio-Products, Inc. (Ramona, CA). An initial immuni-
zation with 150 mg of antigen in complete Freund’s ad-
juvant was performed followed by three subsequent
100-mg booster immunizations in incomplete Freund’s
adjuvant. The E2C serum was affinity purified on GST–
E2C linked to glutathione–agarose beads as described
(Koff, 1992).
Cooperative origin binding assay
A DNA–protein coimmunoprecipitation assay was
used to evaluate the ability of wild-type and mutated HPV
11 E2 proteins to enhance binding of E1 to the origin of
replication. The cooperative binding assay has been
described previously (Sarafi and McBride, 1995; Winokur
and McBride, 1996). Briefly, p11ori was digested with
BamHI, HindIII, and AflIII to produce two larger frag-
ments of DNA containing only plasmid sequences and a
186-bp sequence from HPV 11 which contains the origin
of replication and the flanking E2-binding motifs (nt
7875–130). These fragments were end labeled with
[32P]dCTP and the Klenow fragment of DNA polymerase.
35S-labeled E1 and E2 proteins were generated using
coupled transcription and translation (TNT reticulocyte
lysate system, Promega). An aliquot of each translated
protein was analyzed by SDS–polyacrylamide gel elec-
trophoresis and the radiolabeled full-length proteins
were quantitated using a PhorphorImager. The volumes
of wild-type or mutated E2 proteins were adjusted with
unprogrammed reticulocyte lysate to equalize the con-
centration of E2 protein in each lysate. Twenty microliters
of E1 and/or E2 protein and 10 mg of sonicated salmon
sperm DNA were added to each binding reaction in a
buffer containing a final concentration of 28 mM HEPES,
pH 7.4, 70 mM MgAc, 0.3 mM MgCl2, 5% glycerol, and 1.4
mM DTT. The salt concentration for each reaction was
adjusted to 170 mM using buffer C-300 (20 mM HEPES,
pH 7.9, 25% glycerol, 300 mM NaCl, 1.5 mM MgCl2). Each
reaction was centrifuged (14,000 rpm, 4°C for 5 min) to
remove insoluble aggregates and 100 ng of labeled
p11ori fragments was added. The binding reactions were
incubated 30 min at room temperature and 30 min on ice.
Ten microliters of polyclonal anti-E1C serum was added
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and incubations were continued for 30 min on ice. The
DNA–protein immune complexes were precipitated with
protein A–sepharose beads and washed three times
with NET 200 (50 mM Tris, pH 7.4, 200 mM NaCl, 5 mM
EDTA, 0.1% Triton X-100, 1 mM DTT, PMSF, aprotinin, and
pepstatin A). The beads were resuspended in NET 200
containing 10 mg of tRNA, and complexes were dissoci-
ated with 1% SDS. The mixture was extracted with phe-
nol–chloroform and the DNA isolated by ethanol precip-
itation. In later assays, to ensure that each mutated E2
protein was soluble and that equal quantities of E2
protein were assayed, an aliquot of the SDS-dissociated
mixture was analyzed by SDS–acrylamide gel electro-
phoresis prior to phenol chloroform extraction as de-
scribed by another laboratory (Brokaw et al., 1996). The
precipitated radiolabeled DNA fragments were analyzed
on 6% acrylamide, 13 TBE gels. The amount of copre-
cipitated origin fragment DNA was quantitated using a
PhorphorImager. The fold stimulation in origin binding
was calculated as the quantity of radioactivity present in
E1 and E2 coprecipitated origin DNA divided by the
amount of radioactivity in the origin fragment coprecipi-
tated with the E1 protein alone.
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